1. Home
  2. LTBR vs NPCE Comparison

LTBR vs NPCE Comparison

Compare LTBR & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lightbridge Corporation

LTBR

Lightbridge Corporation

HOLD

Current Price

$16.94

Market Cap

578.2M

ML Signal

HOLD

Logo Neuropace Inc.

NPCE

Neuropace Inc.

HOLD

Current Price

$16.43

Market Cap

328.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LTBR
NPCE
Founded
1992
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
578.2M
328.8M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
LTBR
NPCE
Price
$16.94
$16.43
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$17.00
AVG Volume (30 Days)
1.2M
233.2K
Earning Date
11-05-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$94,864,000.00
Revenue This Year
N/A
$24.82
Revenue Next Year
N/A
$1.28
P/E Ratio
N/A
N/A
Revenue Growth
N/A
24.08
52 Week Low
$4.37
$7.56
52 Week High
$31.34
$18.98

Technical Indicators

Market Signals
Indicator
LTBR
NPCE
Relative Strength Index (RSI) 46.14 67.29
Support Level $15.14 $15.61
Resistance Level $17.95 $17.22
Average True Range (ATR) 1.27 0.95
MACD 0.34 0.05
Stochastic Oscillator 79.41 83.66

Price Performance

Historical Comparison
LTBR
NPCE

About LTBR Lightbridge Corporation

Lightbridge Corp is a United States-based nuclear fuel technology company. The business activity of the firm is functioned through one business segment, which is the development and commercialization of its nuclear fuel. The Nuclear Fuel Technology segment develops next generation nuclear fuel technology that increases the power output of commercial reactors and reduces the cost of generating electricity. Geographically, its operations are functioned through the region of Unites States.

About NPCE Neuropace Inc.

NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.

Share on Social Networks: